March 01, 2021 00:02 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
I appreciate that he doesn’t hide his true self: Congress leader Ghulam Nabi Azad praises Narendra Modi | Aatmanirbhar Bharat is not merely govt efforts, it is national spirit: PM Modi | ISRO launches PSLV-C51 carrying Brazil's Amazonia-1, 18 other satellites | Coronavirus vaccines to be capped at Rs. 250 per shot in private hospitals: Centre | After Mamata Banerjee's show, Smriti Irani rides scooter in Bengal
PM Modi, Chief Ministers to get Covid-19 vaccine in second phase

PM Modi, Chief Ministers to get Covid-19 vaccine in second phase

India Blooms News Service | @indiablooms | 21 Jan 2021, 07:30 pm

New Delhi/IBNS: Prime Minister Narendra Modi will receive coronavirus vaccine  in the second phase of the country-wide immunisation drive along with chief minister and MPs and MLAs over 50, reported the media.

According to reports, health workers and other frontline workers have shown reluctance in taking the vaccine shots, fearing side effects.

NITI Aayog member VK Paul, who heads a government committee on vaccine strategy, said the health workers who are not taking vaccine shots meant for them are not fulfilling "societal responsibility".

"Please understand the whole world is clamouring for vaccines. If our healthcare workers, our doctors and nurses, if they are declining to take it, I feel sorry. I plead with them, on behalf of the government, because we don't know what shape this pandemic will take going forward," Paul was quoted as saying by news agency Reuters.

The vaccine drive was launched on January 16, after the government gave nod to Astrazeneca-manufactured Covishield and Bharat Biotech's Covaxin. In the first phase, the government aimed to vaccinate 30 crore people, including 3 crore health workers.

Reports said states are struggling to meet the vaccination target set by the Centre. So far, "Adverse events" have  been reported in 0.18 per cent of recipients, and only  0.02% cases required hospitalisation from side effects.